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Abstract
V. vulnificus is a Gram-negative bacteri-
um, commonly found in estuarine and
coastal habitats, that can infect humans
through seafood consumption or wound
exposure. This study represents the first
attempt to correlate the genotype of Vibrio
vulnificus strains isolated in the north-west-
ern Adriatic Sea coastal area, with their
antimicrobial susceptibility patterns. On the
whole, 40 V. vulnificus strains, isolated from
shellfish (n=20), different coastal water
bodies (n=19), and the blood of a Carretta
carretta turtle (n=1), were utilized. All
strains were positive for the species-specific
genes vvhA and hsp, with high variability
for other markers: 55% (22 out of 40)
resulted of the environmental (E) genotype
(vcgE, 16S rRNA type A, CPS2 or CPS0),
10% (4 out of 40) of the clinical (C) geno-
type (vcgC, 16S rRNA type B, CPS1), and
35% (14 out of 40) of the mixed (M) geno-
type, possessing both E and C markers. The
antimicrobial susceptibility was assayed by
the diffusion method on agar, according to
the Clinical Laboratory Standards Institute
(CLSI), utilizing the following commercial
disks (Oxoid): ampicillin (AMP), ampi-
cillin-sulbactam (SAM), piperacillin (PRL),
cefazolin (KZ), cefotaxime(CTX), cef-
tazidime(CAZ), imipenem (IPM), meropen-
em (MEM), amikacin (AK),
gentamicin(CN), tetracycline(TE),
ciprofloxacin (CIP), levofloxacin (LEV),
trimethoprim-sulfamethoxazole (SXT), and
chloramphenicol (C). 75% of the strains,
(n=30) including all C strains, was sensitive
to all the tested antibiotics, whereas E
strains showed intermediate sensitivity to
AK (2 strains), CIP and CAZ (1 strain), TE
(1 strain) and resistance to KZ (1 strain),
and 4 M strains showed I to AK. 
Introduction
V. vulnificus is a Gram negative bacil-
lus, natural inhabitant of estuarine and
marine environments. Even if the optimal
environmental conditions for V. vulnificus
are considered the medium or low salinity,
between 5 and 25 ppt, and temperatures
between 20 and 30°C (DePaola et al.,
2006), it has been recovered from fish,
shellfish, water and sediments of a wide
range of temperatures and salinities and
also in effluent from wastewater treatment
plants in Spain (Cañigral et al., 2010) and
South Africa (Igbinosa et al., 2009). 
V. vulnificus can infect humans through
seafood consumption or wound exposure.
In the immunocompromised or individuals
with pre-existing chronic illnesses e.g. liver
disease, chronic alcohol use, cancer, dia-
betes mellitus, infection often leads to pri-
mary or secondary septicaemia respectively
(DePaola et al., 2006). Primary septicaemia
shows an average mortality rate exceeding
50%, and represents the leading cause of
seafood-related death in the US, but wound
infection may also be severe, with a fatality
rate of 25% (Han et al., 2011). 
In Europe V. vulnificus infections are
not nationally notifiable diseases, therefore
today reports are limited to a few cases each
year, even if it is expected an increase of
incidence in the future, due to raw shellfish
consumption, the increasing number of
immune-compromised people, and the
impact of anthropogenic activity and global
warming on the marine environment
(Baker-Austin et al., 2010; Martinez-Urtaza
et al., 2010). 
In Italy, three cases of fatal septicaemia
have been documented: one attributed to
wound infection in a hemodialyzed patient
(Stabellini et al., 1998) and two attributed
to the consumption/manipulation of seafood
products in individuals with chronic liver
disease (Madeddu et al., 2004). Moreover a
case of infection with benign outcome, has
been documented (Benini et al., 1994) and
other cases have been reported by the press
in Rimini, (La Voce di Romagna, 25 August,
2011), leading to a Public Prosecutor’s
Office investigation, whose conclusions
have not yet been made public. 
Actually, three biotypes of V. vulnificus
are recognized and differentiated by bio-
chemical characteristics: biotype 1, indole
positive, which is pathogenic to humans,
biotype 2, indole negative, which is
pathogenic to eels, and biotype 3, indole
positive hybrid of biotypes 1 and 2, which is
pathogenic to humans but has only been
reported in Israel, representing an emerging
form of this species (Thiaville et al., 2011).
For the identification of V. vulnificus
biotype 1 at the species level, two genetic
markers are commonly employed: vvhA
(Neogi et al., 2010) and hsp (Tarr et al.,
2007), and others are commonly utilized to
differentiate clinical (C) from environmen-
tal (E) genotypes, among which: the vcg
gene, with the two variants clinical (vcgC)
and environmental (vcgE) (Han et al.,
2011); the 16S rRNA gene, with the variant
type A being significantly correlated with
environmental strains, and the variant type
B or AB significantly correlated with clini-
cal strains (Nilsson et al., 2003); the CPS
operon group 1, referred to as allele 1
(CPS1) and allele 2 (CPS2), the first more
frequent among clinical strains (87%) and
the latter more frequent among environ-
mental strains (87%) (Chatzidaki-Livanis et
al., 2006), even if strains not typeable for
CPS markers (CPS0) have also been
described (Thiaville et al., 2011). 
The relevance of these factors has been
examined in various in vivo and in vitro
models, but unique virulence markers that
are present exclusively in virulent strains
have not yet been identified, and all clinical
and environmental isolates resulted equally
virulent in animal and cell culture patho-
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genesis models (Mala et al., 2014).
Consequently, at present, according to the
Food and Agricultural Organization of the
United Nations and the World Health
Organization (FAO/WHO, 2005), all V. vul-
nificus strains may be considered virulent,
and there is a broad consensus on the need
for monitoring presence and characteristics
of this waterborne pathogen worldwide.
For a long time vibrios were considered
to be susceptible to all antibiotics except
ampicillin (Zanetti et al., 2001), but more
recent studies on V. vulnificus evidenced an
increase of resistance to different classes of
antibiotics (Ottaviani et al., 2001; Han et
al., 2007; Backer-Austin et al., 2009; Shaw
et al., 2014). In any case, in contrast to the
extensive antibiotic resistance investigation
in other pathogens such as Vibrio cholera
and Salmonella spp., the awareness of
antibiotic resistance of V. vulnificus and V.
parahaemolyticus is considered not well
documented (Elmahdi et al., 2016).
Particularly, only a few studies have been
conducted in Italy on antibiotic susceptibil-
ity of pathogenic vibrios (Ottaviani et al.,
2001; Zanetti et al., 2001). 
The aim of the present study was to
compare the prevalence of V. vulnificus in
different coastal water bodies and shellfish
of the Emilia-Romagna region, and to deter-
mine the relationship between the genotype
and the antimicrobial susceptibility patterns
of the environmental isolates.
Materials and Methods
For the present study, 21 strains of V.
vulnificus belonging to our collection were
utilized together with 19 newly isolates
from different water bodies (n=67) of which
32 from the beach area of Cesenatico, 32
from the brackish waters of Cesenatico (a
channel flowing into the sea and its inland
branch), 3 from the beach area of Rimini. 
Among the 21 collection strains, 20
were isolated from shellfish (Ruditapes
philippinarum) harvested in the Sacca di
Goro lagoon at the Po River delta, and 1
strain was isolated from the blood of a turtle
(Carretta carretta) stranded in the same
area. All isolates were characterized by
means of genotype and antimicrobial sus-
ceptibility patterns. 
Study area and sampling plan
The study area is represented in Figure
1. Surface water samples (50 cm) were col-
lected from June to November, from vari-
ous water bodies of the coastal area of the
Emilia Romagna region: seawater of
Cesenatico at the beach area not directly
influenced by terrestrial water discharges
(SWC1 and SWC2); brackish water of
Cesenatico, partially influenced by terrestri-
al water discharges (a channel flowing into
the sea, indicated as BWC3 and its inland
branch, indicated as BWC4); seawater of
Rimini at the beach area (SWR) periodical-
ly influenced by overflow pipes dumping of
combined wastewater exceeding the capac-
ity of the municipal depuration plant;
Ruditapes philippinarum harvesting area at
Goro. All samples were transported to the
laboratory in isothermal boxes then stored
at 6-8 °C, to avoid viable but nonculturable
conditions of Vibrio spp., and processed
within 24 h. 
Genotyping of isolates
The strains belonging to our collection,
and utilized in the present study, were
already phenotypically characterized and
genotyped as reported elsewhere, and the
newly isolates were characterized following
the same protocol, targeting the genes vvhA,
hsp, vcg, 16S-rRNA, CPS, by the poly-
merase chain reaction (PCR) (Passalacqua
et al., 2016). 
Moreover, reference strains of V. vul-
nificus were utilized as positive controls:
DSM 11507, DSM 10143 (ex ATCC
27562), NCTC 11066 (ex ATCC 29306),
NCTC 11067 (ex ATCC 29307). Reference
strains of V. parahaemolyticus were utilized
as negative controls: ATCC 17802 and
ATCC 43996. 
Antimicrobial susceptibility testing
Antimicrobial susceptibility of isolates
were tested by the disk diffusion method on
Mueller-Hinton agar (Oxoid) according to
the Clinical Laboratory Standards Institute
(CLSI, 2006), utilizing Escherichia coli
ATCC 25922 as control. Particularly the
following antimicrobial (OXOID) were uti-
                             Article
Figure 1. Study area of the Emilia-Romagna region and sampling stations. Goro, clams production area; Cesenatico, beach area (SWC1
and SWC2, white points); Cesenatico, brackish waters (channel flowing into the sea, SWC3, and its inland branch, SWC4, black
points); Rimini, beach area (SWR).
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lized: ampicillin (AMP, 10 µg), ampicillin-
sulbactam (SAM, 10/10 µg), piperacillin
(PRL, 100 µg), cefazolin (KZ, 30 µg), cefo-
taxime (CTX, 30 µg), ceftazidime (CAZ,
30 µg), imipenem (IPM, 10 µg), meropen-
em (MEM, 10 µg), amikacin (AK, 30 µg),
gentamicin (CN, 10 µg), tetracycline (TE,
30 µg), ciprofloxacin (CIP, 5 µg), lev-
ofloxacin (LEV, 5 µg), trimethoprim-sul-
famethoxazole (SXT, 1.25/23.75 µg), and
chloramphenicol (C, 30 µg). The interpreta-
tive criteria, according to the Clinical
Laboratory Standards Institute (CLSI,
2006), are listed in Table 1. 
Results
On the whole, 19 V. vulnificus strains
were newly isolated from 64 water samples
of different sources: from Cesenatico (16
samples at each stations, SWC1, SWC2,
BWC3, BWC4), and Rimini (3 seawater
samples at the beach area SWR). The envi-
ronmental conditions (mean values) at the
water sampling stations at the time of sam-
pling, are reported in Table 2. The samples
from the beach areas of Cesenatico (SWC1,
SWC2) were all negative for V. vulnificus,
whereas 19% (3 out of 16) of the brackish
waters samples SWC3 were positive, as
well as 31% (5 out of 16) of the brackish
waters samples SWC4, and 33% (1 out of 3)
of the seawater samples of the beach area of
Rimini (SWR). The biochemical character-
istics of all isolates utilized in the present
study are omitted, but they resulted all
attributable to the biotype 1, being indole
positive.
Genotyping of isolates
All the 40 strains were positive for the
species-specific genes vvhA and hsp, with
variability for the other markers even in the
same sample (734, 776, 798, 883, 915, 958,
1023): 55% (n=22) were of the environ-
mental (E) genotype (vcgE, 16S rRNA type
A, CPS2), 10% (n=4) of the clinical (C)
genotype (vcgC, 16S rRNA type B, CPS1)
and 35% (n=14) showed a mixed (M) geno-
type. Particularly, among the E strains, 5
resulted untypeable for CPS being negative
for both CPS1 and CPS2 as the reference
strain DSM 11507; among the M strains, 1
resulted positive for both CPS1 and CPS2,
as the reference strains DSM 10143. The
results of the PCR-based genotyping of the
isolates are reported in Table 3.
Antimicrobial susceptibility testing
V. vulnificus reference strains and 75%
(30 out of 40) of the isolates, including all
of them of the C genotype, were sensitive to
all the tested antibiotics. 25% (10 out of 40)
of the isolates, all of them of the E or M
genotype, were sensitive to CTX, AMP,
IPM, MEM, C, CN, PRL, SXT, LEV and
SAM, but showed intermediate sensitivity
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Table 1. Interpretative criteria of the antimicrobial susceptibility test following the Clinical Laboratory Standards Institute (CLSI,
2006).
Antimicrobial class and acronym                                        Antimicrobial agent (disk content)                    Zone diameter (mm)
                                                                                                                                                                                interpretive criteria
                                                                                                                                                                          S                     I                      R
Penicillins and beta-lactam/beta-lactamase inhibitor combinations                                                                                                                               
      AMP                                                                                                                                   Ampicillin (10 µg)                                      ≥17                     14-16                      ≤13
      SAM                                                                                                                      Ampicillin-sulbactam (10/10 µg)                          ≥15                     12-14                      ≤11
      PRL                                                                                                                                 Piperacillin (100 µg)                                    ≥21                     18-20                      ≤17
Cephems                                                                                                                                                                                                                                        
      KZ                                                                                                                                      Cefazolin (30 µg)                                       ≥18                     15-17                      ≤14
      CTX                                                                                                                                  Cefotaxime (30 µg)                                     ≥23                     15-22                      ≤14
      CAZ                                                                                                                                  Ceftazidime (30 µg)                                     ≥18                     15-17                      ≤14
Carbapenems                                                                                                                                                                                                                                
      IPM                                                                                                                                   Imipenem (10 µg)                                      ≥16                     14-15                      ≤13
      MEM                                                                                                                               Meropenem (10 µg)                                    ≥16                     14-15                      ≤13
Aminoglycosides                                                                                                                                                                                                                           
      AK                                                                                                                                       Amikacin (30 µg)                                       ≥17                     15-16                      ≤14
      CN                                                                                                                                    Gentamicin (10 µg)                                     ≥15                     13-14                      ≤12
Tetracyclines                                                                                                                                                                                                                                 
      TE                                                                                                                                    Tetracycline (30 µg)                                    ≥19                     15-18                      ≤14
Quinolones                                                                                                                                                                                                                                    
      CIP                                                                                                                                  Ciprofloxacin (5 µg)                                    ≥21                     16-20                      ≤15
      LEV                                                                                                                                  Levofloxacin (5 µg)                                     ≥17                     14-16                      ≤13
Others                                                                                                                                                                                                                                             
      C                                                                                                                                  Chloramphenicol (30 µg)                                ≥18                     13-17                      ≤12
Folate pathway inhibitors                                                                                                                                                                                                           
      SXT                                                                                                        Trimethoprim-sulfamethoxazole (1.25/23.75 µg)           ≥16                     11-15                      ≤10
Table 2. Environmental conditions at the time of sampling: mean values of temperature,
salinity and dissolved oxygen. 
Station               Temperature (°C)             Salinity (ppt)                 Dissolved O2 (mg/L)
SWC1                                         23.5                                             39.5                                                     5.8
SWC2                                         22.9                                             37.9                                                     6.1
BWC3                                         23.1                                              31                                                      5.5
BWC4                                         23.4                                             33.4                                                     4.3
SWG                                           23.7                                             28.8                                                     7.4
SWR                                           23.2                                             35.2                                                     5.2
SWC1-SWC2, seawater beach area of Cesenatico; BWC3, brackish water of Cesenatico (channel flowing into the sea); BWC4, Cesenatico inland
branch; SWG, seawater of Goro clams production area; SWR, seawater beach area of Rimini.
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to AK (4 strains of the M genotype and 2
strains of the E genotype), to CIP and CAZ
or TE or KZ (4 strains of the E genotype),
and the only one strain showing resistance
to KZ was of the E genotype. FoFor the
detail of the interpretative zone diameter
(mm) see Table 4.
Discussion
V. vulnificus is a halophilic Gram-nega-
tive bacillus, commonly found worldwide
in warm coastal waters with moderate salin-
ity, sediments, and a variety of seafood
including shrimp, fish, and bivalve shellfish
(Jones and Oliver, 2009). 
The water temperature during our study,
ranging from 22.9 to 23.7 °C, was certainly
favourable to V. vulnificus, because a tem-
perature higher than 20°C is largely consid-
ered the most suitable for this organism
                             Article
Table 3. Genotypes of the Vibrio vulnificus strains considered in the study and their source. 
Sample N°/strain N°       Source                 vvhA         hsp            vcgC          16S rRNA B            CPS1        vcgE         16S rRNA A       CPS2
628/7                                                 RG                               +                 +                      -                             -                               +                  +                          +                         -
677/25                                               Cc                               +                 +                      -                             -                                -                   +                          +                        +
731/16                                               RG                               +                 +                      -                             -                                -                   +                          +                        +
731/17                                               RG                               +                 +                      -                             -                                -                   +                          +                        +
731/18                                               RG                               +                 +                      -                             -                                -                   +                          +                        +
734/4                                                 RG                               +                 +                     +                           +                              +                   -                           -                          -
734/6                                                 RG                               +                 +                      -                             -                                -                   +                          +                        +
734/8                                                 RG                               +                 +                      -                             -                               +                  +                          +                         -
734/9                                                 RG                               +                 +                      -                             -                               +                  +                          +                         -
734/14                                               RG                               +                 +                      -                             -                                -                   +                          +                        +
734/15                                               RG                               +                 +                      -                             -                                -                   +                          +                        +
734/16                                               RG                               +                 +                     +                           +                              +                   -                           -                          -
734/17                                               RG                               +                 +                     +                           +                              +                   -                           -                          -
734/18                                               RG                               +                 +                      -                             -                                -                   +                          +                        +
759/14                                               RG                               +                 +                      -                             -                                -                   +                          +                        +
776/6                                                 RG                               +                 +                      -                             -                                -                   +                          +                        +
776/8                                                 RG                               +                 +                      -                             -                                -                   +                          +                        +
776/10                                               RG                               +                 +                      -                             -                                -                   +                          +                         -
786/10                                               RG                               +                 +                     +                           +                              +                   -                           -                          -
798/10                                             SWR                             +                 +                     +                           +                              +                   -                           +                         -
798/12                                             SWR                             +                 +                     +                           +                              +                   -                           +                         -
798/14                                             SWR                             +                 +                     +                           +                              +                  +                          +                         -
798/15                                             SWR                             +                 +                     +                           +                              +                  +                          +                         -
880/3                                              BWC4                            +                 +                      -                             -                                -                   +                          +                         -
883/2                                              BWC3                            +                 +                      -                             -                                -                   +                          +                         -
883/3                                              BWC3                            +                 +                      -                             -                                -                   +                          +                         -
883/4                                              BWC3                            +                 +                      -                             -                                -                   +                          +                         -
883/5                                              BWC3                            +                 +                      -                             -                                -                   +                          +                        +
883/6                                              BWC3                            +                 +                      -                             -                               +                  +                          +                         -
915/2                                              BWC4                            +                 +                      -                             -                                -                   +                          +                        +
915/6                                              BWC4                            +                 +                      -                             -                               +                  +                          +                         -
915/18                                            BWC4                            +                 +                      -                             -                                -                   +                          +                        +
942/3                                              BWC4                            +                 +                      -                             -                               +                   -                           +                         -
945/2                                              BWC3                            +                 +                      -                             -                                -                   +                          +                        +
953/2                                              BWC3                            +                 +                      -                             -                                -                   +                          +                         -
958/4                                              BWC4                            +                 +                      -                             -                               +                  +                          +                         -
958/5                                              BWC4                            +                 +                      -                             -                                -                   +                          +                        +
958/6                                              BWC4                            +                 +                      -                             -                               +                  +                          +                         -
1023/4                                               RG                               +                 +                      -                             -                               +                  +                          +                         -
1023/5                                               RG                               +                 +                     +                            -                               +                  +                          +                        +
Reference strains                                                                                                                                                                                                                            
      DSM 11507                                                                    +                 +                     +                           +                               -                    -                           -                          -
      DSM 10143                                                                    +                 +                      -                             -                               +                  +                          +                        +
      NCTC 11066                                                                  +                 +                      -                             -                                -                   +                          +                        +
      NCTC 11067                                                                  +                 +                     +                           +                               -                    -                           +                        +
RG, Ruditapes philippinarum from Goro; Cc, Carretta carretta, blood; BWC3, brackish water of Cesenatico (channel flowing into the sea); BWC4, Cesenatico inland branch; SWR, seawater of the beach area of Rimini.
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(Cañigral et al., 2010). On the contrary, the
salinity, ranging from 28,8 to 39.5 ppt, was
undoubtedly higher than indicated as suit-
able by many authors (between 15 to 25
ppt), and stressed in the comprehensive
review of Horseman and Surani (2011),
suggesting that temperature and salinity
may be not the only environmental factors
influencing V. vulnificus growth and sur-
vival as speculated by DePaola et al.
(2006). 
Notwithstanding Vibrio spp. abundance
has been largely considered unrelated to
pollution or faecal waste (Cañigral et al.,
2010), a significant correlation between the
occurrence of V. vulnificus and the occur-
rence of faecal indicators was found in the
Danish marine environments (Høi et al.,
1998), moreover V. vulnificus was recov-
ered from effluents of wastewater treatment
plants, suggesting that nutrient enriched and
faecal contaminated water may represent a
favourable environment (Igbinosa et al.,
2009; Cañigral et al., 2010). Accordingly, in
the present study the higher percentage of
positivity for V. vulnificus (33%) was found
in recreational seawater heavily influenced
by wastewater (SWR), followed by brack-
ish water partially influenced by wastewater
(the channel flowing into the sea, SWC3
19%, and its inland branch, SWC4 31%),
whereas all samples from recreational sea-
water not directly influenced by wastewater
(SWC1, SWC2) were all negative for V. vul-
nificus. Moreover, the previously reported
multi-year study on bivalve shellfish
(Ruditapes philippinarum) harvested in the
area of Goro, indicated that only 11,5% of
the samples resulted positive for V. vulnifi-
cus (Serratore et al., 2016). 
Combining these observation, it can be
assumed that, in the area of interest, the
conditions determined by a sizeable amount
of nutrients and wastewater may enhance
the prevalence of V. vulnificus in a water
body more than the filter feeding activity in
bivalve shellfish harvested in a B zone
(Goro), considered moderately fecalized
and classified according to Regulation EC
854/2004 (E. coli exceeding 230
MPN/100g, and ≤ 4.600 MPN/100g).  
The genotyping of V. vulnificus isolates
utilized in the present study showed a high-
er percentage of strains with the E genotype
(55%) with respect to the C genotype
(10%), but also the M genotype was repre-
sented with a high percentage (35%), con-
firming that the recovery of strains with the
M genotype is not uncommon, as reported
elsewhere (Nilsson et al., 2003; Chatzidaki-
Livanis et al., 2006). 
The susceptibility of V. vulnificus to
antibiotics has been studied applying differ-
ent protocols, and the results are often in
disagreement, ranging from sensitivity to
the majority of antibiotics (Han et al., 2007)
to a widespread antibiotic intermediate sen-
sitivity or resistance (Ottaviani et al., 2001;
Baker-Austin et al., 2009; Shaw et al.,
2014). Obviously, it is possible that strains
of different geographical origin may present
different susceptibility to antibiotics, but the
differences amongst the utilized protocols
may also be at the origin of such a variety of
results. In the present study the disk diffu-
sion method on Mueller-Hinton agar,
applied according to the Clinical
Laboratory Standards Institute (CLSI,
2006), showed that 75% of the strains were
sensitive to all the tested antibiotics. The
strains showing intermediate sensitivity or
even resistance (25%) were all of the E
(n=6) and M (n=4) genotype, and amino-
glycosides showed the worst performance,
according to the study of Bier et al. (2015),
but unlike this study, non-susceptibility to
both quinolones (CIP) and cephems (CAZ)
was also observed in one strain. 
A recent extensive review on the antibi-
otic resistance profile of V. vulnificus in the
United States and other countries including
Italy, Brazil, Philippines, Malaysia,
Thailand, China, India, Iran, South Africa
and Australia, indicate that both environ-
mental and clinical isolates show similar
antibiotic resistance profiles (Elmahdi et
al., 2015). Our data are not in agreement
considering that 27% of the E genotype iso-
lates (6 out of 22) and 29% of M genotype
strains (4 out of 14) showed intermediate
sensitivity to AK, or CIP and CAZ, or TE,
or KZ, or resistance to KZ, whereas the
strains of the C genotype were 100% sensi-
tive to all the tested antibiotics, as the refer-
ence strains.
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Table 4. Vibrio vulnificus strains showing intermediate sensitivity or resistance to the tested antibiotics. 
Strain      Source        CTX       CIP       CAZ     AMP     IPM      MEM       AK         TE        C        CN     PRL        SXT      KZ     LEV      SAM
734/15               RG                  S               S               S             S             S               S                S                I             S            S            S                 S             S            S               S
                                                                                                                                                                     (18)           
776/6                 RG                  S               S               S             S             S               S                S                S            S            S            S                 S              I            S               S
                                                                                                                                                                                                                                                   (17)          
776/8                 RG                  S               S               S             S             S               S                I               S            S            S            S                 S             S            S               S
                                                                                                                                                   (16)              
798/10             SWR                 S               S               S             S             S               S                I                S            S            S            S                 S             S            S               S
                                                                                                                                                   (16)              
915/2              BWC4                S               I               I              S             S               S                S                S            S            S            S                 S             S            S               S
                                                                (20)         (16)            
945/2              BWC3                S               S               S             S             S               S                I                S            S            S            S                 S             S            S               S
                                                                                                                                                   (16)              
953/2              BWC3                S               S               S             S             S               S                S                S            S            S            S                 S             R            S               S
                                                                                                                                                                                                                                                   (12)          
958/4              BWC4                S               S               S             S             S               S                I                S            S            S            S                 S             S            S               S
                                                                                                                                                   (16)              
1023/4               RG                  S               S               S             S             S               S                I                S            S            S            S                 S             S            S               S
                                                                                                                                                   (16)              
1023/5               RG                  S               S               S             S             S               S                I                S            S            S            S                 S             S            S               S
                                                                                                                                                   (16)              
BWC3, brackish water of Cesenatico (channel flowing into the sea); BWC4, Cesenatico inland branch; SWR, seawater beach area of Rimini; RG, Ruditapes philippinarum from Goro; Cc, Carretta carretta, blood; AMP,
ampicillin; SAM, ampicillin-sulbactam; PRL, piperacillin; KZ, cefazolin; CTX, cefotaxime; CAZ, ceftazidime; IPM, imipenem; MEM, meropenem; AK, amikacin; CN, gentamicin; TE, tetracycline; CIP, ciprofloxacin; LEV, lev-
ofloxacin; SXT, trimethoprim-sulfamethoxazole; C, chloramphenicol; S, sensitivity; I, intermediate sensitivity; R, resistance. Zone diameter is expressed as mm.
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Conclusions
Notwithstanding V. vulnificus infection
is considered one of the few foodborne ill-
nesses with an increasing incidence world-
wide (Bross et al., 2007), and the mortality
rate may increase to 100% in patients with
septicemia if treatment is delayed by 72 h
(Bross et al., 2007), the awareness of
antimicrobial resistance of V. vulnificus is
not as well documented as for other food-
borne bacterial pathogens (Elmahdi et al.,
2015). 
The present study evidenced the
intraspecific variability of genotypes of V.
vulnificus isolates even in the same sample,
and confirmed that aminoglycosides show
the worst performance against V. vulnificus
as previously reported (Bier et al., 2015),
but at odds with previously reported studies
(Elmahdi et al., 2015) a different antimicro-
bial patterns among the different genotypes
was also evidenced. Moreover our study
documents non-susceptibility to cef-
tazidime (CAZ), ciprofloxacin (CIP), and
tetracycline (TE), conversely indicated
among the recommended antibiotics for the
treatment of V. vulnificus infections
(Elmahdi et al., 2015). 
It can be concluded that more extensive
studies are needed to characterize the
antimicrobial susceptibility of the environ-
mental strains of V. vulnificus with respect
to their geographical origin, and to individ-
uate the appropriate first-line antimicro-
bials, enabling clinicians to apply a timely
and adequate medical therapy in case of
human infection. 
References
Baker-Austin C, McArthur JV, Lindell AH,
Wright MS, Tuckfield RC, Gooch J,
Warner L, Oliver JD, Stepanauskas R,
2009. Multi-site analysis reveals
widespread antibiotic resistance in the
marine pathogen Vibrio vulnificus.
Microb Ecol 57:151-59.
Baker-Austin C, Stockley L, Rangdale R,
Martinez-Urtaza J, 2010.
Environmental occurrence and clinical
impact of Vibrio vulnificus and Vibrio
parahaemolyticus: a European perspec-
tive. Environ Microbiol Rep 2:7-18.
Benini F, Laghi S, Martinelli M, Resta F,
Gaddoni G, Fanciulli A, Golinelli MP,
1994. Sepsi da Vibrio vulnificus:
Descrizione di un caso clinico.
Microbiol Med 9:569-70.
Bier N, Schwartz K, Guerra B, Strauch E,
2015. Survey on antimicrobial resistan-
ce patterns in Vibrio vulnificus and
Vibrio cholerae non-O1/non-O139 in
Germany reveals carbapenemase-pro-
ducing Vibrio cholerae in coastal
waters. 2015. Front Microbiol 6:1-11.
Bross MH, Soch K, Morales R, Mitchell
RB, 2007. Vibrio vulnificus infection:
diagnosis and treatment. Am Fam
Physician 76:539-44.
Cañigral I, Moreno Y, Alonso JL, González
A, Ferrús MA, 2010. Detection of
Vibrio vulnificus in seafood, seawater
and wastewater samples from a
Mediterranean coastal area. Microbiol
Res 165:657-64.
Chatzidaki-Livanis M, Hubbard MA,
Gordon K, Harwood WJ, Wright AC,
2006. Genetic distinctions among clini-
cal and environmental strains of Vibrio
vulnificus. Appl Environ Microbiol
72:6136-41.
CLSI, 2006. Method for antimicrobial dilu-
tion and disk susceptibility testing of
infrequently isolated or fastidious bac-
teria. Approved standard M45A 1st ed.
Clinical and Laboratory Standards
Institute, Wayne, PA, USA. 
DePaola A, Lee R, Mahoney D, Rivera I,
Tamplin M, 2006. Case study: Vibrio
vulnificus in oysters. Background paper
for the joint FAO/WHO expert consul-
tation on development of practical risk
management strategies based on micro-
biological risk assessment outputs. Joint
FAO/WHO, Kiel, Germany, pp 1-30. 
Elmahdi S, DaSilva LV, Parveen S, 2016.
Antibiotic resistance of Vibrio para-
haemolyticus and Vibrio vulnificus in
various countries: a review. Food
Microbiol 57:128-34.
European Commission, 2004. Regulation of
the European Parliament and of the
Council of 29 April 2004 laying down
specific rules for the organization of
official controls on products of animal
origin intended for human consump-
tion. Official Journal of the European
Union, L226, 83-127.
Food and Agricultural Organization of the
United Nations/World Health
Organization (FAO/WHO), 2005. Risk
assessment of Vibrio vulnificus in raw
oysters. Interpretative summary and
technical report. Microbiological Risk
Assessment series N°8. Joint
FAO/WHO, Rome, Italy, pp 3-114. 
Han F, Walker RD, Janes ME,
Prinyawiwatkul W, Ge B, 2007.
Antimicrobial susceptibilities of Vibrio
parahaemolyticus and Vibrio vulnificus
isolates from Louisiana Gulf and retail
raw oysters. Appl Environ Microbiol
73:7096-8.
Han F, Wang F, Ge B, 2011. Detecting
potentially virulent Vibrio vulnificus
strains in raw oysters by quantitative
loop-mediated isothermal amplifica-
tion. Appl Environ Microbiol 77:2589-
95. 
Høi L, Larsen JL, Dalsgaard I, Dalsgaard A,
1998. Occurrence of Vibrio vulnificus
biotypes in Danish marine environ-
ments. Appl Environ Microbiol 64:7-13
Horseman MA, Surani S, 2011. A compre-
hensive review of Vibrio vulnificus: an
important cause of severe sepsis and
skin and soft-tissue infection. Int J
Infect Dis 15:e157-66.
Igbinosa EO, Obi LC, Okoh AI, 2009.
Occurrence of potentially pathogenic
vibrios in final effluents of a wastewater
treatment facility in a rural community
of the Eastern Cape Province of South
Africa. Res Microbiol 160:531-7.
Jones MK, Oliver JD, 2009. Vibrio vulnifi-
cus: disease and pathogenesis. Infect
Immun 77:1723-33.
Madeddu S, Scarano C, Dessì MA,
Palomba P, Crasta M, 2004.
Monitoraggio per la ricerca di Vibrio
vulnificus in acque e prodotti della
pesca nelle lagune della provincia di
Cagliari. Atti del XIV Convegno
Nazionale Associazione Italiana
Veterinari Igienisti, 2004 giugno 4-6,
Cuneo, Italy, AIVI, pp. 105-10.
Mala W, Chomvarin C, Alam M, Rashed
SM, Faksri K, Angkititrakul S, 2014.
Molecular analysis of Vibrio vulnificus
isolated from cockles and patients in
Thailand. Southeast Asian J Trop Med
Public Health 45:103-12.
Martinez-Urtaza, J, Bowers JC, Trinanes J,
DePaola A, 2010. Climate anomalies
and the increasing risk of Vibrio para-
haemolyticus and Vibrio vulnificus ill-
nesses. Food Res Int 43:1780-90.
Neogi SB, Chowdhury N, Asakura M,
Hinenoya A, Haldar S, Saidi SM,
Kogure K, Lara RJ, Yamasaki S, 2010.
A highly sensitive and specific multi-
plex PCR assay for simultaneous detec-
tion of Vibrio cholerae, Vibrio para-
haemolyticus and Vibrio vulnificus.
Lett Appl Microbiol 51:293-300.
Nilsson WB, Paranjype RN, DePaola A,
Strom MS, 2003. Sequence polymor-
phism of the 16S rRNA gene of Vibrio
vulnificus is a possible indicator of
strain virulence. J Clin Microbiol
41:442-46.
Ottaviani D, Bacchiocchi I, Masini L, Leoni
F, Carraturo A, Giammarioli M,
Sbaraglia G, 2001. Antimicrobial sus-
ceptibility of potentially pathogenic
halophilic vibrios isolated from
seafood. Int J Antimicro Ag 18:135-40.
Passalacqua PL, Zavatta E, Bignami G,
Serraino A, Serratore P, 2016.
                             Article
No
n c
om
me
cia
l u
se
 on
ly
                                 [Italian Journal of Food Safety 2017; 6:6843]                                                 [page 151]
Occurrence of Vibrio parahaemolyticus,
Vibrio cholerae and Vibrio vulnificus in
the clam Ruditapes philippinarum
(Adams & Reeve, 1850) from Emilia
Romagna and Sardinia, Italy. Ital J Food
Safety 5:e5709.
Serratore P, Ostanello F, Passalacqua PL,
Zavatta E, Bignami G, Serraino A,
Giacometti F, 2016. First multi-year ret-
rospective study on Vibrio para-
haemolyticus, and Vibrio vulnificus
prevalence in Ruditapes philippinarum
harvested in Sacca di Goro, Italy. Ital J
Food Safety 5: e6161.
Shaw KS, Rosenberg Goldstein RE, He X,
Jacobs JM, Crump BC, Sapkota AR,
2014. Antimicrobial susceptibility of
Vibrio vulnificus and Vibrio para-
haemolyticus recovered from recre-
ational and commercial areas of
Chesapeake bay and Maryland coastal
bays. PLoS ONE 9:e89616. 
Stabellini N, Camerani A, Lambertini D,
Rossi MR, Bettoli V, Virgili A, Gilli P,
1998. Fatal sepsis from Vibrio vulnifi-
cus in a hemodialyzed patient. Nephron
2:221-4.
Tarr CL, Patel JS, Puhr ND, Sowers EG,
Bopp CA, Strockbine NA, 2007.
Identification of Vibrio isolates by a
multiplex PCR assay and rpoB
sequence determination. J Clin
Microbiol 45:134-40.
Thiaville PC, Bourdage KL, Wright AC,
Farrell-Evans M, Wilson Garvan C,
Gulig PA, 2011. Genotype is correlated
with but does not predict virulence of
Vibrio vulnificus biotype 1 in subcuta-
neously inoculated, iron dextran-treated
mice. Infect Immun 79:1194-207.
Zanetti S, Spanu T, Deriu A, Romano L,
Sechi LA, Fadda G, 2001. In vitro sus-
ceptibility of Vibrio spp. isolated from
the environment. Int J Antimicro Ag
17:407-09. 
                                                                                                                              Article
No
n c
om
me
rci
al 
us
e o
nly
